Trials / Completed
CompletedNCT01839695
Safety and Efficacy of Valiant Mona LSA Stent Graft System
Valiant Mona LSA Stent Graft System Early Feasibility Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Medtronic Cardiovascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Valiant Mona LSA thoracic stent graft system is for the endovascular repair of aneurysms of the descending thoracic aorta (DTA) in patients who require coverage of the left subclavian artery (LSA).The study is intended to assess safety and performance of the device acutely and at 30 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Valiant Mona LSA Stent Graft System | All subjects will be implanted with this device |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2014-02-01
- Completion
- 2018-12-01
- First posted
- 2013-04-25
- Last updated
- 2023-07-03
- Results posted
- 2014-10-29
Locations
3 sites across 2 countries: United States, United Kingdom
Source: ClinicalTrials.gov record NCT01839695. Inclusion in this directory is not an endorsement.